Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced…
read moreVision enhancement platform eSight has launched a program that allows employees who are visually impaired to become productive in…
read moreCorbus Pharmaceuticals says a Phase 3 clinical trial of anabasum for diffuse cutaneous scleroderma will start in the fourth…
read moreRegroup Mass Notification, industry-leading provider of emergency and day-to-day communication solutions, today announced that it will be the only…
read moreZetrOZ Systems, a leading USA-based medical device manufacturer, was selected by the National Institute of Aging to present its…
read moreThanks to the community, a young boy is going to be able to see better than ever.
Corbin Wolfe’s family…
UltraCell Insulation on list of finalists. Read more >>
read moreEvery year, CNBC scans the globe looking for the 100 venture-backed start-ups that have the potential to transform industries…
read moreUltraCell Insulation, a runner-up in the 43North business plan competition in 2016, has wrapped up a $5 million funding…
read moreHoth Therapeutics, Inc., a biopharmaceutical company, today announced top line data from its Cutaneous Lupus Erythematosus (CLE) study, a…
read more